These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29668199)

  • 1. [Assessment of ECG and holter parameters among patients with systemic sclerosis].
    Przegl Lek; 2016; 73(6):364-7. PubMed ID: 29668199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiography in 110 patients with systemic sclerosis: a cross-sectional comparison with population-based controls.
    Nordin A; Björnådal L; Larsson A; Svenungsson E; Jensen-Urstad K
    Scand J Rheumatol; 2014; 43(3):221-5. PubMed ID: 24392822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of non-invasive assessment of arrhythmias, conduction disturbances and cardiac autonomic tone in systemic sclerosis and systemic lupus erythematosus.
    Bienias P; Ciurzyński M; Kisiel B; Chrzanowska A; Ciesielska K; Siwicka M; Kalińska-Bienias A; Saracyn M; Lisicka M; Radochońska J; Pruszczyk P
    Rheumatol Int; 2019 Feb; 39(2):301-310. PubMed ID: 30421103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients.
    Ferri C; Bernini L; Bongiorni MG; Levorato D; Viegi G; Bravi P; Contini C; Pasero G; Bombardieri S
    Arthritis Rheum; 1985 Nov; 28(11):1259-66. PubMed ID: 4063000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of heart rhythm variability and arrhythmia in children with systemic and localized scleroderma.
    Wozniak J; Dabrowski R; Luczak D; Kwiatkowska M; Musiej-Nowakowska E; Kowalik I; Szwed H
    J Rheumatol; 2009 Jan; 36(1):191-6. PubMed ID: 19040309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic markers for the prediction of ventricular arrhythmias in patients with systemic sclerosis.
    Sebestyén V; Szűcs G; Páll D; Ujvárosy D; Ötvös T; Csige I; Pataki T; Lőrincz I; Szabó Z
    Rheumatology (Oxford); 2020 Mar; 59(3):478-486. PubMed ID: 31943100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS).
    Clements PJ; Furst DE; Cabeen W; Tashkin D; Paulus HE; Roberts N
    Am J Med; 1981 Jul; 71(1):38-46. PubMed ID: 7246582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular profiles of scleroderma patients with arrhythmias and conduction disorders.
    Muresan L; Petcu A; Pamfil C; Muresan C; Rinzis M; Mada RO; Gusetu GN; Pop D; Zdrenghea D; Rednic S
    Acta Reumatol Port; 2016; 41(1):26-39. PubMed ID: 27115105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analyses of ventricular arrhythmias in patients with progressive systemic scleroderma (PSS) by ambulatory electrocardiography].
    Kawase H; Hirano M; Takagi M; Noma A; Maeda M; Mori S; Ohashi H
    Rinsho Byori; 1993 Nov; 41(11):1271-4. PubMed ID: 8283805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias.
    Yiu KH; Schouffoer AA; Marsan NA; Ninaber MK; Stolk J; Vlieland TV; Scherptong RW; Delgado V; Holman ER; Tse HF; Huizinga TW; Bax JJ; Schuerwegh AJ
    Arthritis Rheum; 2011 Dec; 63(12):3969-78. PubMed ID: 22127711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac arrhythmias and conduction disturbances in patients with ankylosing spondylitis.
    Kazmierczak J; Peregud-Pogorzelska M; Biernawska J; Przepiera-Bedzak H; Goracy J; Brzosko I; Plonska E; Brzosko M
    Angiology; 2007 Dec-2008 Jan; 58(6):751-6. PubMed ID: 18216383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of dynamic electrocardiographic monitoring in scleroderma patients].
    Palermo R; Tulli D; Moretti S; Balestra E; Pratillo G; Conti V
    Minerva Cardioangiol; 1990 May; 38(5):199-203. PubMed ID: 2234450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ECG and 24-hour ECG findings in athletes of static and dynamic disciplines].
    Płońska E; Kamiński L; Peregud M; Szyszka A; Wojtarowicz A; Kaźmierczak J; Kornacewicz-Jach Z
    Pol Merkur Lekarski; 2006 Apr; 20(118):390-4. PubMed ID: 16886558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrocardiographic disorders in diverse clinical variations of scleroderma].
    Targa L; Cardin G; Cozzi F; Glorioso S; Rossi L; Todesco S
    G Clin Med; 1990 Jan; 71(1):17-24. PubMed ID: 2142111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate turbulence impairment and ventricular arrhythmias in patients with systemic sclerosis.
    Bienias P; Ciurzyński M; Glińska-Wielochowska M; Korczak D; Kalińska-Bienias A; Gliński W; Pruszczyk P
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):920-8. PubMed ID: 20456648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying arrhythmias in adults with congenital heart disease by 24-h ambulatory electrocardiography.
    Rodriguez FH; Moodie DS; Neeland M; Adams GJ; Snyder CS
    Pediatr Cardiol; 2012 Apr; 33(4):591-5. PubMed ID: 22318853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmias and Conduction Disturbances in Patients with Systemic Sclerosis-A Systematic Literature Review.
    Vrancianu CA; Gheorghiu AM; Popa DE; Chan JSK; Satti DI; Lee YHA; Hui JMH; Tse G; Ancuta I; Ciobanu A; Bojinca M
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Ventricular Arrhythmias, Conduction Disorders, and Myocardial Fibrosis in Patients With Systemic Sclerosis.
    Muresan L; Oancea I; Mada RO; Petcu A; Pamfil C; Muresan C; Rinzis M; Pop D; Zdrenghea D; Rednic S
    J Clin Rheumatol; 2018 Jan; 24(1):25-33. PubMed ID: 29200022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.